Bank of America’s Dynavax Technologies DVAX Stock Holding History

Bank of America’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-415,000	Closed	-$4M	–	7090
2017 Q2	$4M	Buy	+415,000	New	+$2.69M	﹤0.01%	3249
2014 Q4	–	Sell	-1,270	Closed	-$18K	–	7730
2014 Q3	$18K	Buy	1,270 +710	+127%	+$10.2K	﹤0.01%	7096
2014 Q2	$9K	Sell	560 -200	-26%	-$3.02K	﹤0.01%	7497
2014 Q1	$14K	Sell	760 -270	-26%	-$5.01K	﹤0.01%	7065
2013 Q4	$20K	Buy	1,030 +810	+368%	+$11.9K	﹤0.01%	7026
2013 Q3	$3K	Sell	220 -20	-8%	-$252	﹤0.01%	7533
2013 Q2	$3K	Buy	+240	New	+$5.06K	﹤0.01%	7447

Other funds holding DVAX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's DVAX Position: Q1 2026 in Review

Bank of America sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 1,057,175 shares — an estimated $16.3M sold.

Bank of America first reported a position in DVAX in Q2 2013 and held it in 51 quarters. The position peaked at $42.6M in Q1 2023. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

Bank of America reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
Bank of America sold 1,057,175 Dynavax Technologies shares in Q1 2026, an estimated $16.3M.
Bank of America first reported a position in Dynavax Technologies in Q2 2013 and held it in 51 quarters.
Bank of America's Dynavax Technologies position peaked at $42.6M in Q1 2023.
1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.